Protagonist Therapeutics
PTGX
#3892
Rank
S$3.35 B
Marketcap
$56.29
Share price
4.93%
Change (1 day)
91.02%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$3.65

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.64. In 2022 the company made an earnings per share (EPS) of -$3.53 an increase over its 2021 EPS that were of -$3.66.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.653.56%
2022-$3.53-3.7%
2021-$3.6635%
2020-$2.71-33.33%
2019-$4.0774.42%
2018-$2.33-20.74%
2017-$2.94-45.64%
2016-$5.4257.3%
2015-$3.44

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.96-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA